PIK3CA and neoplasm: After detecting the volume and weight of the resulting tumors, we found that the silencing of METTL3 led to a significant delay in tumor growth, with the effect becoming evident from Day 8 and persisting through Day 28, whereas the treatment in combination with PIK3CA overexpression relieved the effects (Figures 7A,B and S3).